Generic lamotrigine equivalent to branded version, study shows
Epilepsy Society has welcomed the findings of a new study which shows that the performance of the generic version of lamotrigine is equivalent to the original branded version of the the anti-epileptic medication.
Doctors in new warning about epilepsy drug valproate
Results of a Europe-wide review of the epilepsy drug valproate, known to cause birth defects, has resulted in the Government sending strengthened warnings to all prescribing doctors and pharmacists.
Brain's natural valium could stop seizures, scientists say
Researchers at Stanford University School of Medicine have found that a naturally occurring protein secreted only in discrete areas of the mammalian brain may act as a Valium-like brake on certain types of epileptic seizures.
Light therapy for people with epilepsy
Bright light therapy – commonly used to treat seasonal affective disorder – can reduce levels of depression and anxiety in patients with epilepsy, according to new research published online today by the British Journal of Psychiatry. Epilepsy Society’s consultant neuropsychologist Dr Sallie Baxendale was the lead researcher in the study of more than 100 patients with focal epilepsy not controlled by medication
Temporary delay in delivery of Epilim and Frisium
We have been informed by Sanofi that there has been a temporary delay to the delivery of some medicines including Epilim and Frisium.
Medication update
We have been informed by Teva UK that Zonisamide 25/50/100mg is currently out of stock.